As of January 2025 Verastem Oncology has a market cap of €0.25 Billion. This makes Verastem Oncology the world's 7835th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 29th, 2025 the market cap of Verastem Oncology was reported to be: